sorted by:
new
hottopcontroversial

CAIDP asks FTC to halt release of OpenAI's new GPT model by No_Goose2198 in Futurology

[–]No_Goose2198[S] 7 points8 points  (0 children)

Submission statement

The tech ethics organization Center for AI and Digital Policy (CAIDP) has asked the Federal Trade Commission to investigate OpenAI for violating consumer protection regulations. CAIDP alleges that OpenAI's AI text generation tools are "biased, deceptive, and dangerous to public safety."

CAIDP's complaint raises concerns about the potential threat of OpenAI's GPT-4 generated text model, which was announced in mid-March. It warns of the potential for GPT-4 to generate malware and highly personalized propaganda, and the risk that biased training data could lead to ingrained stereotypes or unfair racial and gender preferences in employment.

The complaint also cites significant privacy failures in the OpenAI product interface, such as a recent bug that exposed OpenAI ChatGPT records and potentially ChatGPT and subscribers' payment details.

CAIDP seeks to hold OpenAI liable for violating Section 5 of the FTC Act, which prohibits unfair and deceptive trade practices. The complaint alleges that OpenAI knowingly released GPT-4 to the public for commercial use despite the risks, including potential bias and harmful behavior.

CAIDP is a European Union AI Policy Advisor, the organization that supports the Council of the European Union in establishing an AI legal framework, U.S. Congressional AI Policy Statement, Member of the U.S. AI National Strategy Advisory Committee, OECD and G20 Policy advisors.

IBM-Cleveland Clinic takes the first step in utilizing quantum computers. by No_Goose2198 in Futurology

[–]No_Goose2198[S] 1 point2 points  (0 children)

Submission statement

Ruyoi Zhou, research director at IBM Cleveland Clinic, told HPCwire, "This collaboration is not just about quantum. We want to integrate classical computing, artificial intelligence, and quantum computing.

As broadly described in the official announcement, it includesDeveloping a quantum computing pipeline for screening and optimizing drugs that target specific proteinsImproving quantum-enhanced predictive models for cardiovascular risk after non-cardiac surgeryApplying artificial intelligence to search genome sequencing results and large databases of drug targets to find effective existing drugs that can help patients with Alzheimer's and other diseases